arrow
F

Francesca Fortunato

N/A
H指数:32
被引数:2,712

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rotavirus Vaccine Effectiveness Against Hospitalization for Rotavirus Gastroenteritis in Children Under 5 years: A Test-Negative Study in Southern Italy, 2018–2025

5岁以下儿童轮状病毒胃肠炎住院的轮状病毒疫苗效果:意大利南部2018–2025年一项测试阴性研究

2026-11-030
OAAI
Neoplasms arising at the CIED pocket: a hybrid study combining a case report, scoping review, and clinical survey

CIED植入囊袋内发生的肿瘤:一项结合病例报告、范围综述和临床调查的混合研究

2026-01-080
OAAI
Association of socio-economic and clinical factors with influenza vaccination uptake in high-risk individuals: an Italian retrospective cohort study, 2019–2023

社会经济和临床因素与高风险人群流感疫苗接种率的相关性:一项意大利回顾性队列研究,2019–2023

2025-12-270
OAAI
IL-6 and IL-8 elevations after co-administration of COVID-19 and influenza vaccines are associated with lower anti-spike IgG titers at three and six months post-vaccination

COVID-19和流感疫苗联合接种后IL-6和IL-8水平的升高与疫苗接种后3个月和6个月抗刺突蛋白IgG滴度的降低有关

2025-11-060
PRE
Real-World Effectiveness of Nirsevimab in Preventing RSV Hospitalizations: Evidence of Protection in Southern Italian Infants, 2024–2025

Nirsevimab在预防RSV住院治疗中的真实世界有效性:2024–2025年意大利南部婴儿的保护证据

2025-10-300
OAAI
Early Warning Approach to Identify Positive Cases of SARS-CoV-2 in School Settings in Italy

意大利学校环境中识别SARS-CoV-2阳性病例的早期预警方法

2025-08-200
PRE
Cost of universal immunization with Nirsevimab vs. standard of practice for infants in their first RSV season. Foggia District, Italy, 2023–2024

与标准实践相比,在首次RSV季节对婴儿进行Nirsevimab普遍免疫的成本。意大利福贾区,2023–2024。

Vaccine
IF3.5
2025-07-310
PRE
Six-month follow-up of antibody response to bivalent mRNA SARS-CoV-2 vaccine booster in healthcare workers

六个月随访:医疗保健工作者对二价mRNA SARS-CoV-2疫苗加强针的抗体反应

Vaccine
IF3.5
2025-07-300
OA
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition

从2023年10月到2024年4月在意大利传播的JN.1变异: 遗传多样性和免疫识别

2025-02-280
OAAI
Delirium Incidence and Predictors in SARS-CoV-2 Vaccinated Residents in Long-Term Care Facilities (LTCF): Insights from the GeroCovid Vax Study
2024-11-010
OAAI
A 12-month follow-up of the immune response to SARS-CoV-2 primary vaccination: evidence from a real-world study

对SARS-CoV-2初次接种疫苗的免疫反应进行12个月的随访: 来自现实世界研究的证据

2023-11-201
OAAI